<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01624779</url>
  </required_header>
  <id_info>
    <org_study_id>KOR-01</org_study_id>
    <nct_id>NCT01624779</nct_id>
  </id_info>
  <brief_title>Intrathecal Transplantation Of Autologous Adipose Tissue Derived MSC in the Patients With Spinal Cord Injury</brief_title>
  <official_title>The Effect of Intrathecal Transplantation of Autologous Adipose Tissue Derived Mesenchymal Stem Cells in the Patients With Spinal Cord Injury, Phase I Clinical Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bukwang Pharmaceutical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bukwang Pharmaceutical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The effect of intrathecal transplantation of autologous adipose tissue derived mesenchymal
      stem cells in the patients with spinal cord injury, Phase I Clinical study.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2012</start_date>
  <completion_date type="Actual">May 2014</completion_date>
  <primary_completion_date type="Actual">May 2014</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Significant MRI Change before and after intervention</measure>
    <time_frame>6 month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Significant neurologic funtion Change before and after intervention</measure>
    <time_frame>6 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Significant Electrophysiological Change before and after intervention</measure>
    <time_frame>6 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse event</measure>
    <time_frame>6 month</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Spinal Cord Injury</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>autologous adipose tissue derived mesenchymal stem cells</intervention_name>
    <description>autologous adipose tissue derived mesenchymal stem cells 9x107cells / 3mL Day 1 and Month 1&amp;2</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patient who don't have any possiblity of improving neurological function despite
             performed the optimal treatment after spinal cord injury

          2. No change in neurological function for 4weeks interval by at least 2 clincal medical
             specialists

          3. Patient who is able to give written informed consent of clinical trial about stemcells
             treatment

        Exclusion Criteria:

          1. Patient who is under 19 years and over 70years

          2. Patient who must use the mechanical ventilator

          3. Patient who have a history of malignant tumor within 5 years

          4. Patient who is having a infectious disease of including current hepatitis and HIV

          5. Patient who had the brain or spinal cord injury before the spinal cord injury (confirm
             subject's history from their medical history)

          6. Patient who is having a acute disease judged by principle investigator or having a
             fever over 38.0 â„ƒ at the vaccination day

          7. Patient who is having an anemia or thrombopenia

          8. Patient who is having an angina, myocardial infarct, myocardiopathy, obstructive
             vessel disease, chronic renal failure, glomerulopathy and chronic obstruent lung
             disease (confirm subject's history from their medical history)

          9. Patient who is having a Congenital Immune Deficiency Syndrome or AIDS (confirm
             subject's history from their medical history)

         10. Patient who is having an amyotrophia or joint atrophy

         11. Patient who is having an disturbanace of consciousness or dysphrasia

         12. Patient who is taking an immunosuppressive agents or corticosteroids agents or
             cytotoxic agents or needed administration

         13. Patient who have experienced another clinical trials within 3 months involving this
             clinical trial

         14. Patient who can't participate in this clinical trial having any opinion regarded as
             clinical significance judged by principle investigator
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Taehyeong Jo, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Korea University Anam Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Korea University Anam Hospital</name>
      <address>
        <city>Seoul</city>
        <state>Seongbukgu</state>
        <zip>136-705</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>June 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 18, 2012</study_first_submitted>
  <study_first_submitted_qc>June 19, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 21, 2012</study_first_posted>
  <last_update_submitted>February 11, 2015</last_update_submitted>
  <last_update_submitted_qc>February 11, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 13, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>autologous adipose tissue</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Spinal Cord Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

